Table 3.
Total (n=9,721) | Hypertension
|
Diabetes mellitus
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Crude
|
Adjusted*
|
Crude
|
Adjusted*
|
|||||||||
OR | 95% CI | p | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
Lean/normal without MetS | Reference | Reference | Reference | Reference | ||||||||
Overweight/obesity without MetS | 2.19 | 1.80–2.67 | <0.001 | 1.93 | 1.57–2.38 | <0.001 | 2.48 | 1.58–3.90 | <0.001 | 1.94 | 1.22–3.10 | 0.005 |
Lean/normal with MetS | 5.00 | 3.91–6.38 | <0.001 | 3.53 | 2.75–4.55 | <0.001 | 7.18 | 4.57–11.3 | <0.001 | 4.68 | 2.93–7.46 | <0.001 |
Overweight/obesity with MetS | 5.10 | 4.10–6.35 | <0.001 | 4.27 | 3.38–5.39 | <0.001 | 9.78 | 6.80–14.3 | <0.001 | 7.10 | 4.74–10.6 | <0.001 |
Hyperuricemia | 2.10 | 1.78–2.47 | <0.001 | 1.36 | 1.13–1.63 | 0.001 | 2.64 | 1.89–3.68 | <0.001 | 1.38 | 0.96–1.99 | 0.080 |
Serum uric acid (per 1 mg/dL increased) | 1.36 | 1.30–1.43 | <0.001 | 1.19 | 1.11–1.27 | <0.001 | 1.55 | 1.40–1.72 | <0.001 | 1.27 | 1.10–1.45 | <0.001 |
Sex (men) | 1.92 | 1.68–2.20 | <0.001 | 1.31 | 1.10–1.55 | 0.002 | 2.84 | 2.07–3.90 | <0.001 | 1.89 | 1.28–2.78 | 0.001 |
| ||||||||||||
Men (n=4,160) | ||||||||||||
Lean/normal without MetS | Reference | Reference | Reference | Reference | ||||||||
Overweight/obesity without MetS | 1.54 | 1.21–1.96 | <0.001 | 1.60 | 1.25–2.06 | <0.001 | 1.64 | 0.98–2.76 | 0.062 | 1.71 | 1.005–2.90 | 0.048 |
Lean/normal with MetS | 3.59 | 2.52–5.11 | <0.001 | 3.00 | 2.10–4.31 | <0.001 | 4.45 | 2.38–8.33 | <0.001 | 3.36 | 2.54–14.5 | <0.001 |
Overweight/obesity with MetS | 3.24 | 2.49–4.22 | <0.001 | 3.43 | 2.61–4.52 | <0.001 | 5.70 | 3.65–8.89 | <0.001 | 5.86 | 0.090–5.96 | <0.001 |
Hyperuricemia | 1.38 | 1.13–1.69 | 0.002 | 1.24 | 1.002–1.53 | 0.048 | 1.56 | 1.06–2.30 | 0.025 | 1.24 | 0.82–1.88 | 0.30 |
Serum uric acid (per 1 mg/dL increased) | 1.70 | 1.53–1.90 | <0.001 | 1.12 | 1.03–1.21 | 0.006 | 1.30 | 1.12–1.51 | <0.001 | 1.21 | 1.03–1.43 | 0.017 |
| ||||||||||||
Women (n=5,561) | ||||||||||||
Lean/normal without MetS | Reference | Reference | Reference | Reference | ||||||||
Overweight/obesity without MetS | 2.83 | 1.99–4.03 | <0.001 | 2.71 | 1.89–3.90 | <0.001 | 2.89 | 1.11–7.50 | 0.029 | 2.38 | 0.91–6.23 | 0.077 |
Lean/normal with MetS | 6.46 | 4.61–9.07 | <0.001 | 3.91 | 2.74–5.59 | <0.001 | 11.8 | 6.06–23.0 | <0.001 | 6.56 | 3.24–13.3 | <0.001 |
Overweight/obesity with MetS | 8.84 | 5.84–13.4 | <0.001 | 6.28 | 4.01–9.78 | <0.001 | 16.6 | 7.91–34.9 | <0.001 | 9.46 | 4.21–21.3 | <0.001 |
Hyperuricemia | 3.25 | 2.37–4.45 | <0.001 | 1.63 | 1.15–2.31 | 0.006 | 4.42 | 2.27–8.61 | <0.001 | 1.75 | 0.84–3.65 | 0.138 |
Serum uric acid (per 1 mg/dL increased) | 1.16 | 1.08–1.25 | <0.001 | 1.29 | 1.14–1.45 | <0.001 | 1.97 | 1.52–2.55 | <0.001 | 1.34 | 1.01–1.79 | 0.042 |
n: number of subjects; MetS: metabolic syndrome; OR: odds ratio; CI: confidence interval
Data adjusted for age, sex, smoking and drinking habits, chronic kidney disease, body mass index and metabolic syndrome category (lean/normal and overweight/obesity with and without metabolic syndrome), and hyperuricemia (or serum uric acid).